112 related articles for article (PubMed ID: 31925916)
1. Delayed methotrexate clearance and acute kidney injury after high-dose methotrexate chemotherapy concurrent with dasatinib in a patient with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia: A case report.
Morota H; Saito S; Uchida E; Okura E; Matsuoka D; Hidaka Y; Natsume T; Watanabe T; Shigemura T; Morita D; Tanaka M; Kurata T; Sakashita K; Nakazawa Y
Pediatr Blood Cancer; 2020 Apr; 67(4):e28173. PubMed ID: 31925916
[No Abstract] [Full Text] [Related]
2. Concurrent Imatinib Dosing With High-dose Methotrexate Leads to Acute Kidney Injury and Delayed Methotrexate Clearance in Pediatric Patients With Philadelphia Chromosome-positive B-Cell Acute Lymphoblastic Leukemia.
Pommert L; Liberio N; Ng JS; Egelund TA; Siver MJ; Katzenstein HM; Burke MJ
J Pediatr Hematol Oncol; 2021 Mar; 43(2):e296-e300. PubMed ID: 32398599
[TBL] [Abstract][Full Text] [Related]
3. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.
Steinberg M
Clin Ther; 2007 Nov; 29(11):2289-308. PubMed ID: 18158072
[TBL] [Abstract][Full Text] [Related]
4. Subdural Hematoma Associated with Dasatinib and Intrathecal Methotrexate Treatment in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia.
Ureshino H; Nishioka A; Kojima K; Kizuka H; Sano H; Shindo T; Kubota Y; Ando T; Kimura S
Intern Med; 2016; 55(18):2703-6. PubMed ID: 27629971
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up of a phase 2 study of chemotherapy plus dasatinib for the initial treatment of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Ravandi F; O'Brien SM; Cortes JE; Thomas DM; Garris R; Faderl S; Burger JA; Rytting ME; Ferrajoli A; Wierda WG; Verstovsek S; Champlin R; Kebriaei P; McCue DA; Huang X; Jabbour E; Garcia-Manero G; Estrov Z; Kantarjian HM
Cancer; 2015 Dec; 121(23):4158-64. PubMed ID: 26308885
[TBL] [Abstract][Full Text] [Related]
6. Acute kidney injury and delayed methotrexate clearance in an adult patient with Philadelphia chromosome-positive acute lymphoblastic leukaemia treated with imatinib.
Chen C; Qi J; Li X; Yongjing W
Eur J Hosp Pharm; 2023 Sep; 30(5):e28. PubMed ID: 36732034
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous subdural hematoma in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia with normal platelet count after dasatinib treatment.
Mustafa Ali MK; Sabha MM; Al-Rabi KH
Platelets; 2015; 26(5):491-4. PubMed ID: 25025538
[TBL] [Abstract][Full Text] [Related]
8. A case of ovarian stimulation for fertility preservation in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia after treatment with dasatinib.
Ogawa T; Ogi M; Hirata S
J Obstet Gynaecol Res; 2021 Mar; 47(3):1182-1185. PubMed ID: 33469980
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic post-transplant dasatinib administration in a pediatric patient with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Watanabe A; Chansu S; Ogawa A; Asami K; Imamura M
Pediatr Int; 2013 Jun; 55(3):e56-8. PubMed ID: 23782380
[TBL] [Abstract][Full Text] [Related]
10. Use of dasatinib dose-reduction periods to remedy poor surgical wound healing in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Roberts KE; Deininger MW; Hildebrandt GC; Gackenbach BK; Krem MM
Leuk Lymphoma; 2020 Dec; 61(14):3507-3510. PubMed ID: 32835547
[No Abstract] [Full Text] [Related]
11. Successful second allogeneic stem cell transplantation in second remission induced by dasatinib in a child with Philadelphia chromosome positive acute lymphoblastic leukemia.
Millot F; Cividin M; Brizard F; Chomel JC; Méchinaud F; Guilhot F
Pediatr Blood Cancer; 2009 Jul; 52(7):891-2. PubMed ID: 19202569
[TBL] [Abstract][Full Text] [Related]
12. A Higher Dose of Dasatinib May Increase the Possibility of Crossing the Blood-brain Barrier in the Treatment of Patients With Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia.
Gong X; Li L; Wei H; Liu B; Zhou C; Zhang G; Liu K; Lin D; Gong B; Wei S; Li Y; Mi Y; Wang Y; Wang J
Clin Ther; 2021 Jul; 43(7):1265-1271.e1. PubMed ID: 34120773
[TBL] [Abstract][Full Text] [Related]
13. Delayed methotrexate clearance in patients with acute lymphoblastic leukemia concurrently receiving dasatinib.
Ramsey LB; Mizuno T; Vinks AA; O'Brien MM
Pediatr Blood Cancer; 2019 May; 66(5):e27618. PubMed ID: 30677213
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of patients with development of large granular lymphocyte expansion among dasatinib-treated patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic stem cell transplantation.
Ito Y; Miyamoto T; Kamimura T; Aoki K; Henzan H; Aoki T; Shiratsuchi M; Kato K; Nagafuji K; Ogawa R; Eto T; Iwasaki H; Akashi K
Clin Lymphoma Myeloma Leuk; 2015 Mar; 15(3):e47-54. PubMed ID: 25445469
[TBL] [Abstract][Full Text] [Related]
15. Bilateral subdural hemorrhage as a serious adverse event of dasatinib in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Yhim HY; Kim HS; Lee NR; Song EK; Kwak JY; Yim CY
Int J Hematol; 2012 May; 95(5):585-7. PubMed ID: 22403059
[No Abstract] [Full Text] [Related]
16. [Clinical Analysis of Dasatinib and Chemotherapy Followed by Allogeneic Hematopoietic Stem Cell Transplantation for Treatment of Patients with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia].
Li Y; Wang BJ; Liu W; Liang ZY; Yin Y; Dong YJ; Wang Q; Sun YH; Xu WL; Ren HY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):18-23. PubMed ID: 32027247
[TBL] [Abstract][Full Text] [Related]
17. Dasatinib-Induced Colitis after Allogeneic Stem Cell Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.
Aldoss I; Gaal K; Al Malki MM; Ali H; Nakamura R; Forman SJ; Pullarkat V
Biol Blood Marrow Transplant; 2016 Oct; 22(10):1900-1903. PubMed ID: 27346662
[TBL] [Abstract][Full Text] [Related]
18. Dasatinib and low-intensity chemotherapy for Philadelphia chromosome-positive acute lymphoblastic leukemia in a child with Down syndrome.
Hirabayashi S; Hasegawa D; Yamamoto K; Nishimura A; Hosoya Y; Shuo T; Kiyokawa N; Miura M; Takahashi N; Manabe A
Pediatr Blood Cancer; 2019 May; 66(5):e27612. PubMed ID: 30663211
[No Abstract] [Full Text] [Related]
19. Targeting BCL-2 and ABL/LYN in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Leonard JT; Rowley JS; Eide CA; Traer E; Hayes-Lattin B; Loriaux M; Spurgeon SE; Druker BJ; Tyner JW; Chang BH
Sci Transl Med; 2016 Aug; 8(354):354ra114. PubMed ID: 27582059
[TBL] [Abstract][Full Text] [Related]
20. Long-term molecular remission in Philadelphia-positive acute lymphoblastic leukemia elderly patient after dasatinib discontinuation.
Vigna E; Gentile M; Giagnuolo G; Recchia AG; Bossio S; De Stefano L; Morelli R; Morabito F
Leuk Lymphoma; 2016 Oct; 57(10):2445-7. PubMed ID: 26879289
[No Abstract] [Full Text] [Related]
[Next] [New Search]
